sars-cov-2 ii-key peptide vaccine
sars-cov-2 ii-key peptide vaccine: developed by 1 company. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| NUGENEREX IMMUNO-ONCOLOGY, INC. (NGIO) | Preclinical |
Get deeper analysis on sars-cov-2 ii-key peptide vaccine
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis